,
An EU-based multinational pharmaceutical company approached Freyr for clinical amendments business imperatives.
The client had an urgent requirement of timely clinical amendment submissions to FDA. With Freyr’s support, the submission was made in a timely manner with the necessary details required by the Health Agency.
Download the proven case now.
Fill the form below to download the Case Study
